
CURE spoke with experts about possible dermatologic adverse effects faced by patients with breast cancer.
Alex Biese is the managing editor of CURE.

CURE spoke with experts about possible dermatologic adverse effects faced by patients with breast cancer.

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.

"The analysis showed a statistically significant, positive effect of normal serum vitamin D levels on increasing ORR and PFS as a result of anti-PD‐1 immunotherapy in patients with locally advanced inoperable or metastatic melanoma,” according to a recent study.

Published: August 3rd 2023 | Updated: